GMED Past Earnings image   This GMED past earnings page last updated 8/8/2022
GMED Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/4/20220.560
Q1 20225/10/20220.420
Q4 20212/17/20220.490
Q3 202111/4/20210.500
Q2 20218/4/20210.560
Q1 20215/4/20210.490
Q4 20202/17/20210.580
Q3 202010/28/20200.490
Q2 20208/5/20200.070
Q1 20205/7/20200.290
Q4 20192/20/20200.490
Q3 201911/6/20190.430
Q2 20198/1/20190.410
Q1 20195/2/20190.360
Q4 20182/21/20190.43
Q3 201811/8/20180.39
Q2 20188/1/20180.44
Q1 20185/2/20180.41
Q4 20172/21/20180.38
Q3 201711/8/20170.3
Q2 20178/2/20170.32
Q1 20175/3/20170.32
Q4 20162/27/20170.31
Q3 201611/8/20160.29
Q2 20167/26/20160.29
Q1 20165/3/20160.29
Q4 20152/24/20160.32
Q3 201511/3/20150.28
Q2 20157/30/20150.25
Q1 20155/5/20150.26
Q4 20142/25/20150.3
Q3 201410/30/20140.24
Q2 20148/5/20140.23
Q1 20144/29/20140.24
Q4 20132/26/20140.25
Q3 201310/30/20130.22
Q2 20138/1/20130.21
Q1 20135/2/20130.21
Q4 20122/27/20130.22
Q3 201211/1/20120.18
Q2 20128/21/20120.21
Q1 20125/1/20120.19
GMED Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/4/20220.26B
Q1 20225/10/20220.23B
Q4 20212/17/20220.25B
Q3 202111/4/20210.23B
Q2 20218/4/20210.25B
Q1 20215/4/20210.23B
Q4 20202/17/20210.23B
Q3 202010/28/20200.22B
Q2 20208/5/20200.15B
Q1 20205/7/20200.19B
Q4 20192/20/20200.21B
Q3 201911/6/20190.20B
Q2 20198/1/20190.19B
Q1 20195/2/20190.18B
Q4 20182/21/2019195.94M
Q3 201811/8/2018169.24M
Q2 20188/1/2018173.38M
Q1 20185/2/2018174.41M
Q4 20172/21/2018176.03M
Q3 201711/8/2017151.74M
Q2 20178/2/2017152.39M
Q1 20175/3/2017155.81M
Q4 20162/27/2017151.59M
Q3 201611/8/2016135.65M
Q2 20167/26/2016137.49M
Q1 20165/3/2016139.26M
Q4 20152/24/2016142.59M
Q3 201511/3/2015136.99M
Q2 20157/30/2015133.57M
Q1 20155/5/2015131.60M
Q4 20142/25/2015128.80M
Q3 201410/30/2014117.80M
Q2 20148/5/2014113.60M
Q1 20144/29/2014114.20M
Q4 20132/26/2014115.20M
Q3 201310/30/2013107.20M
Q2 20138/1/2013107.00M
Q1 20135/2/2013105.00M
Q4 20122/27/2013100.50M
Q3 201211/1/201294.80M
Q2 20128/21/201295.98M
Q1 20125/1/201294.72M
Quotes delayed 20 minutes

Email EnvelopeFree GMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Globus Medical (GMED) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

GMTX Past Earnings
GNCA Past Earnings
GNPX Past Earnings
GOSS Past Earnings
GOVX Past Earnings
GRAY Past Earnings
GRPH Past Earnings
GRTS Past Earnings
GRTX Past Earnings
GTBP Past Earnings

GMED Past Earnings Q&A

What was the best and worst GMED past earnings results?
For Globus Medical, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest GMED past earnings result in our data set was 0.580/share posted in Q4 2020, while the lowest was in Q2 2020 when GMED posted 0.070/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when GMED reported 0.26B in revenue, while the quarter with the lowest revenue in our data set was Q1 2012 at 94.72M of revenue.

  Suggested answer: There are 42 GMED past earnings results in our data set.

On this page we presented the GMED past earnings date information for Globus Medical. Reviewing that GMED Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2020, when GMED posted adjusted EPS of 0.580/share. Meanwhile the lowest GMED past earnings result was in Q2 2020, when GMED posted adjusted EPS of 0.070/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when GMED reported 0.26B in revenue, while the smallest revenue quarter was Q1 2012 when GMED reported 94.72M in revenue.

Any self directed investor doing their due diligence on GMED or any other given stock can benefit from researching all of the Globus Medical past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Globus Medical past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for GMED. Thanks for visiting, and the next time you need to research GMED past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding EOCA, CYTK Options Chain, MWJ Videos.

 

GMED Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.